$SNOA
Sonoma Pharmaceuticals, Inc.

2024 Q4 Form 10-Q Financial Statement

#000168316824007708 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $3.579M
YoY Change 31.05%
Cost Of Revenue $2.218M
YoY Change 27.4%
Gross Profit $1.361M
YoY Change 37.47%
Gross Profit Margin 38.03%
Selling, General & Admin $1.705M
YoY Change 2.59%
% of Gross Profit 125.28%
Research & Development $506.0K
YoY Change -5.6%
% of Gross Profit 37.18%
Depreciation & Amortization $35.00K
YoY Change -12.5%
% of Gross Profit 2.57%
Operating Expenses $2.211M
YoY Change 0.59%
Operating Profit -$850.0K
YoY Change -29.64%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $387.0K
YoY Change -530.0%
Pretax Income -$463.0K
YoY Change -64.33%
Income Tax $147.0K
% Of Pretax Income
Net Earnings -$610.0K
YoY Change -58.89%
Net Earnings / Revenue -17.04%
Basic Earnings Per Share -$0.59
Diluted Earnings Per Share -$0.59
COMMON SHARES
Basic Shares Outstanding 1.339M shares 19.15M shares
Diluted Shares Outstanding 1.034M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.078M
YoY Change 90.56%
Cash & Equivalents $4.078M
Short-Term Investments
Other Short-Term Assets $2.149M
YoY Change -53.78%
Inventory $2.837M
Prepaid Expenses
Receivables $3.157M
Other Receivables $0.00
Total Short-Term Assets $12.22M
YoY Change 6.12%
LONG-TERM ASSETS
Property, Plant & Equipment $255.0K
YoY Change -41.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $76.00K
YoY Change 1.33%
Total Long-Term Assets $1.464M
YoY Change -30.91%
TOTAL ASSETS
Total Short-Term Assets $12.22M
Total Long-Term Assets $1.464M
Total Assets $13.69M
YoY Change 0.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $770.0K
YoY Change -21.99%
Accrued Expenses $2.138M
YoY Change 11.35%
Deferred Revenue
YoY Change
Short-Term Debt $82.00K
YoY Change -51.76%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.309M
YoY Change 2.16%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $5.024M
YoY Change 6.44%
Total Long-Term Liabilities $5.024M
YoY Change 6.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.309M
Total Long-Term Liabilities $5.024M
Total Liabilities $8.333M
YoY Change 4.69%
SHAREHOLDERS EQUITY
Retained Earnings -$196.1M
YoY Change 1.92%
Common Stock $205.7M
YoY Change 2.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.352M
YoY Change
Total Liabilities & Shareholders Equity $13.69M
YoY Change 0.37%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$610.0K
YoY Change -58.89%
Depreciation, Depletion And Amortization $35.00K
YoY Change -12.5%
Cash From Operating Activities $354.0K
YoY Change -128.78%
INVESTING ACTIVITIES
Capital Expenditures $26.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$26.00K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.444M
YoY Change -1303.33%
NET CHANGE
Cash From Operating Activities 354.0K
Cash From Investing Activities -26.00K
Cash From Financing Activities 1.444M
Net Change In Cash 1.772M
YoY Change -231.26%
FREE CASH FLOW
Cash From Operating Activities $354.0K
Capital Expenditures $26.00K
Free Cash Flow $328.0K
YoY Change -126.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Entity Registrant Name
EntityRegistrantName
SONOMA PHARMACEUTICALS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
68-0423298
dei Entity Address Address Line1
EntityAddressAddressLine1
5445 Conestoga Court
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 150
dei Entity Address City Or Town
EntityAddressCityOrTown
Boulder
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80301
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
759-9305
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3714000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2902000 usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3128000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2898000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
2719000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3541000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
12548000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
365000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
286000 usd
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1145000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
66000 usd
CY2024Q1 us-gaap Assets
Assets
14740000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
607000 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
478000 usd
CY2024Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
323000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3719000 usd
CY2024Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
87000 usd
CY2024Q1 SNOA Withholding Tax Payable
WithholdingTaxPayable
4710000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
87000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
8603000 usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
203209000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-194349000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2723000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
6137000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14740000 usd
CY2023Q3 us-gaap Revenues
Revenues
2731000 usd
us-gaap Revenues
Revenues
6970000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2218000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1753000 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001367083
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33216
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
dei Trading Symbol
TradingSymbol
SNOA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1339170 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4078000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3157000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
2837000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1929000 usd
CY2024Q3 SNOA Deferred Consideration Current
DeferredConsiderationCurrent
220000 usd
CY2024Q1 SNOA Deferred Consideration Current
DeferredConsiderationCurrent
262000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
12221000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
255000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
162000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
792000 usd
CY2024Q3 SNOA Deferred Consideration Noncurrent
DeferredConsiderationNoncurrent
179000 usd
CY2024Q1 SNOA Deferred Consideration Noncurrent
DeferredConsiderationNoncurrent
330000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
76000 usd
CY2024Q3 us-gaap Assets
Assets
13685000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
770000 usd
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
2022000 usd
CY2024Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
2113000 usd
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
319000 usd
CY2024Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
82000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
116000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
198000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3309000 usd
CY2024Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
45000 usd
CY2024Q3 SNOA Withholding Tax Payable
WithholdingTaxPayable
4933000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
46000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
8333000 usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
24000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1338615 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1338615 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
780371 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
780371 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
205651000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-196102000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4197000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
5352000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13685000 usd
CY2024Q3 us-gaap Revenues
Revenues
3579000 usd
us-gaap Revenues
Revenues
6158000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1741000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4303000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3964000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
1361000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
990000 usd
us-gaap Gross Profit
GrossProfit
2667000 usd
us-gaap Gross Profit
GrossProfit
2194000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
506000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
536000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
976000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
861000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1705000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1662000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3781000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
2211000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
2198000 usd
us-gaap Operating Expenses
OperatingExpenses
4690000 usd
us-gaap Operating Expenses
OperatingExpenses
4642000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-850000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1208000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2023000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2448000 usd
CY2024Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
387000 usd
CY2023Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-90000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
563000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-301000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-463000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1298000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1460000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2749000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
147000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
186000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
293000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
153000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-610000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1484000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2902000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.59
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.75
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.75
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-11.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-11.47
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1034000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1034000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
258000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
258000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
943000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
943000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
253000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
253000 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-610000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1484000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1753000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2902000 usd
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-593000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-213000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-1474000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
298000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1203000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1697000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3227000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2604000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1753000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
74000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
90000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
121000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
307000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-188000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-144000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
427000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-375000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
370000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-403000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1134000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-47000 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
99000 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
104000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-102000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-79000 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
219000 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
132000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
62000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-353000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-128000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-31000 usd
SNOA Increase Decrease In Withholding Tax Payable
IncreaseDecreaseInWithholdingTaxPayable
223000 usd
SNOA Increase Decrease In Withholding Tax Payable
IncreaseDecreaseInWithholdingTaxPayable
238000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-102000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-79000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-558000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1446000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
31000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2289000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-5000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
33000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
SNOA Payments For Fractional Shares Related To Reversesplit
PaymentsForFractionalSharesRelatedToReversesplit
1000 usd
SNOA Payments For Fractional Shares Related To Reversesplit
PaymentsForFractionalSharesRelatedToReversesplit
-0 usd
us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
241000 usd
us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
259000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2080000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-264000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-541000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
950000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1683000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3128000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3820000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4078000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2137000 usd
us-gaap Interest Paid Net
InterestPaidNet
8000 usd
us-gaap Interest Paid Net
InterestPaidNet
10000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
6137000 usd
CY2024Q2 SNOA Proceeds From Atthemarket Sale Of Common Stock Net Of Offering Expenses
ProceedsFromAtthemarketSaleOfCommonStockNetOfOfferingExpenses
748000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
107000 usd
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-881000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1143000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
4975000 usd
CY2024Q3 SNOA Proceeds From Atthemarket Sale Of Common Stock Net Of Offering Expenses
ProceedsFromAtthemarketSaleOfCommonStockNetOfOfferingExpenses
1541000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
26000 usd
CY2024Q3 SNOA Stock Issued During Period Values Reverse Stock Splits
StockIssuedDuringPeriodValuesReverseStockSplits
-1000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14000 usd
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-593000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-610000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
5352000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
7977000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-5000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
177000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
511000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1418000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
7242000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
130000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-213000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1484000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5675000 usd
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
The reverse stock split reduced the number of shares of the Company’s common stock outstanding from 21,174,693 to 1,058,447. The total number of authorized shares of common stock was not proportionally decreased and the par value per share of the common stock continues to be $0.0001.
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-610000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1484000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1753000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2902000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-196102000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-194349000 usd
CY2024Q3 SNOA Working Capital
WorkingCapital
8912000 usd
CY2024Q1 SNOA Working Capital
WorkingCapital
8829000 usd
CY2024Q3 SNOA Liquidity Cash Balance
LiquidityCashBalance
4078000 usd
CY2024Q1 SNOA Liquidity Cash Balance
LiquidityCashBalance
3128000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-558000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1446000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_z1elHG8SIoji" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_86C_zD48YVLKPbB1">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent liabilities at the dates of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from these estimates. Significant estimates and assumptions include reserves and write-downs related to receivables and inventories, the valuation allowance relating to the Company’s deferred tax assets, valuation of equity and the estimated amortization periods of upfront product licensing fees received from customers. Periodically, the Company evaluates and adjusts estimates accordingly.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-610000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1484000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1753000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2902000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1034000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1034000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
258000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
258000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
943000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
943000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
253000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
253000 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.59
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.75
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.75
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-11.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-11.47
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
42000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
33000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
42000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
33000 shares
CY2024Q3 SNOA Allowance For Sales Discounts Rebates Distributor Fees And Returns
AllowanceForSalesDiscountsRebatesDistributorFeesAndReturns
66000 usd
CY2024Q1 SNOA Allowance For Sales Discounts Rebates Distributor Fees And Returns
AllowanceForSalesDiscountsRebatesDistributorFeesAndReturns
27000 usd
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
254000 usd
CY2024Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
296000 usd
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1670000 usd
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1802000 usd
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1421000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1213000 usd
CY2024Q3 us-gaap Inventory Gross
InventoryGross
3091000 usd
CY2024Q1 us-gaap Inventory Gross
InventoryGross
3015000 usd
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
254000 usd
CY2024Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
296000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
2837000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
2719000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
162000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
286000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
116000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
198000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
46000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
87000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
186000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
102000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P18M21D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0600 pure
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
87000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
67000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
14000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
9000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
177000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
15000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
162000 usd
us-gaap Officers Compensation
OfficersCompensation
586000 usd
CY2024Q3 SNOA Potential Severance Payments
PotentialSeverancePayments
1300000 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
24000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
14000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
130000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
121000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
307000 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.315 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.205 pure
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3579000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2731000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6970000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6158000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3579000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2731000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6970000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6158000 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-007708-index-headers.html Edgar Link pending
0001683168-24-007708-index.html Edgar Link pending
0001683168-24-007708.txt Edgar Link pending
0001683168-24-007708-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
snoa-20240930.xsd Edgar Link pending
sonoma_ex1401.htm Edgar Link pending
sonoma_ex3101.htm Edgar Link pending
sonoma_ex3102.htm Edgar Link pending
sonoma_ex3201.htm Edgar Link pending
sonoma_i10q-093024.htm Edgar Link pending
snoa-20240930_cal.xml Edgar Link unprocessable
snoa-20240930_def.xml Edgar Link unprocessable
snoa-20240930_lab.xml Edgar Link unprocessable
snoa-20240930_pre.xml Edgar Link unprocessable
sonoma_i10q-093024_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable